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Propositions belonging to the thesis:
SET and SET-CAN in human leukemia
1. It would be worthwhile to screen patients with gastrointestinal tumors
for the presence of SET-CAN fusion gene because its ectopic
expression in transgenic mice results in spontaneous hyperplasia of
stomach mucosa.
     (This Thesis)
2. The demonstration of the RNAi-induced reduction of pp32 decreases
the amount of SET and results in less acetylated histone H4 conflicts
with their inhibitory role on histone acetylation.
      Brody et al. (2004) American Journal of Pathology 164:273-283
      Seo et al. (2001) Cell 104:119-130
3. It has not been proven that tight regulation of the 2 isoforms of SET is
important for the correct chromatin remodeling activity by the SET
heterodimer.
     Yamaguchi et al. (1999) J. Mol. Biol. 290:547-557
4. Given that little has been done to precisely determine the differential
expression pattern of the alpha and beta forms of SET ignores the
possibility that this might provide further insight into the involvement of
this gene in hematopoietic cell proliferation and differentiation.
5. Studies aimed at the identification of the expression signature of
metastasis, as well as that of cancer stem cells will only provide key
information for the development of novel therapeutic agents to cure
cancer if expression profiling is done with highly purified cell
populations and the correct controls.
Minn et al. (2005) Nature 436:518-524
Weigelt et al (2005) Nat Rev Cancer 5(8):591-602
6. Despite the opposition of the Bush administration and the long way to
go to clinical application, recent generation of patient-specific human
embryonic stem cells, derived from nuclear transfer of somatic cells
from patients, will accelerate therapeutic-cloning studies.
Hwank et al. (2005) Science 308:1777-1783
7. The poor coincidence in expression profiles between different papers
using Affimetrix arrays to identify genes crucial for the development of
alveolar rhabdomyosarcoma (ARMS) is more likely to reflect
differences in experimental approach than the inability of expression
arrays to identify such genes.
Khan et al. (2003) Nature Med. 7, 674-679
Kappler et al. (2004) Oncogene 23, 8785-8795
 Wachtel et al. (2004) Cancer Research 64, 5539-5545
8. The claim that a shortened form of the AML1-ETO fusion protein
would be important for leukemogenesis in t(8;21) AML, is more based
on poor experimentation than careful analysis of AML1-ETO isoforms
in t(8;21) patient material.
Yan et al. (2004) PNAS 101:17186-17191
9. The suggestion that SOCS4 and SOCS5 mediate turnover of the EGF
receptor via ubiquitin-mediated degradation does not take into account
the established role of the Cbl E3-ligase in this process.
Kario et al. (2005) JBC 280, 7038-7048
Nicholson et al. (2005) PNAS 102, 2328-2333
10. It is never too late to screw up an experiment (Ned Mantei).
11. No matter how old a car is in Memphis, its indicators remain brand
new.
